Unspecified GLP-1
Sold by Helimeds · Injection, vial · every unspecified glp-1 record
Price
| Term | Published rate | Charged today |
|---|---|---|
| Refill (4-week supply, after starter plan) “Next 4-week supply orders $239.00” | $239Per 4 weeks | Charged today$239 |
| EasyStart - 3 months “EasyStart - 3 months SAVE $420 $99 / month” | $99Published figure | Charged todayNot verified |
| Any dose - 3 month “Any dose - 3 month $199 / month” | $199Published figure | Charged todayNot verified |
Price sources
- Refill (4-week supply, after starter plan) · helimeds.com — read September 2026
- EasyStart - 3 months · helimeds.com — read September 2026
- Any dose - 3 month · helimeds.com — read September 2026
We earn nothing from this link. It opens Helimeds's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | What if I need to cancel? To cancel, contact [email protected] . We offer flexible cancellation with no fees or long-term contract commitments. |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from helimeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — The site's /treatments/semaglutide page is titled 'Compounded GLP-1' and never actually uses the word 'semaglutide' in its visible text, so that product is recorded as unspecified GLP-1 rather than compounded semaglutide -- it does, however, explicitly say the '3 month supply of the medication will arrive in a single vial,' confirming injection-vial. The tirzepatide page never states vial vs pen. Footer branding is 'Travex Inc'; 'Helimeds' is the storefront brand name used throughout the visible copy.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.